![Eugene Marcantonio](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eugene Marcantonio
Vorstandsvorsitzender bei ARMGO Pharma, Inc.
Profil
Eugene Marcantonio is currently the Chief Executive Officer & Director at ARMGO Pharma, Inc. He has been in this position since 2021.
Prior to his current role, Eugene obtained a doctorate degree from New York University School of Medicine.
Aktive Positionen von Eugene Marcantonio
Unternehmen | Position | Beginn |
---|---|---|
ARMGO Pharma, Inc.
![]() ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Vorstandsvorsitzender | 01.01.2021 |
Ausbildung von Eugene Marcantonio
New York University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
ARMGO Pharma, Inc.
![]() ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Health Technology |